SCHEMBL7707536

SCHEMBL7707536

COC(=O)C/C=C/c1ccc(OC2CCCC2)c2oc3ccccc3c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.43
CYP11B1 P15538 1/20 0.43
CYP11B2 P19099 1/20 0.43
KDM4E B2RXH2 3/20 0.37
ALDH1A1 P00352 3/20 0.37
MAPT P10636 1/20 0.37
HSD17B10 Q99714 1/20 0.37
PDE4B Q07343 6/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
HTT P42858 1/20 0.36
PDE4A P27815 3/20 0.35
PDE4C Q08493 3/20 0.35
PDE4D Q08499 3/20 0.35
SSTR5 P35346 1/20 0.35
PDE10A Q9Y233 1/20 0.34
CYP2C19 P33261 1/20 0.34
NPC1 O15118 1/20 0.34
GAA P10253 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7707366 0.82 CYP19A1 (0.45) CYP19A1CYP11B1CYP11B2PDE4BHTT
SCHEMBL5018006 0.79 CYP19A1 (0.49) CYP19A1CYP11B1CYP11B2KDM4EPDE4B
SCHEMBL8272708 0.76 CYP19A1 (0.42) CYP19A1CYP11B1CYP11B2ALDH1A1MAPT
SCHEMBL5022607 0.74 CYP19A1 (0.48) CYP19A1CYP11B1CYP11B2PDE4BKMT2A
SCHEMBL8298197 0.72 CYP19A1 (0.47) CYP19A1CYP11B1CYP11B2HSD17B10PDE4B
SCHEMBL8271921 0.72 GAA (0.44) CYP19A1CYP11B1CYP11B2KDM4EALDH1A1
SCHEMBL5016456 0.71 PDE4B (0.51) CYP19A1CYP11B1CYP11B2KDM4EALDH1A1
SCHEMBL7328799 0.69 PDE4B (0.57) PDE4BPDE4APDE4CPDE4D
SCHEMBL5023416 0.68 CYP19A1 (0.50) CYP19A1CYP11B1CYP11B2KDM4EALDH1A1
SCHEMBL5025269 0.67 PDE4D (0.43) CYP19A1CYP11B1CYP11B2PDE4BPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011132051-A2 TRICYCLE COMPOUNDS AS PHOSPHODIESTERASE-10 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2011-10-27 WO disclosed